Cohort study reveals significant associations between aluminum exposure from vaccines and neurodevelopmental disorders in children, suggesting safety concerns.
Andersson et al. published “Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood: A Nationwide Cohort Study” with a discussion and conclusion that contradicts the data. Aluminum adjuvant safety studies are largely underwhelming, irrelevant to injectable aluminum, and are not designed to discover neurodevelopmental disease. The manuscript matches the original supplemental, where many neurodevelopmental diagnoses were deleted, but not the updated supplemental showing association to neurodevelopmental disease. Neurodevelopmental disorders such as Asperger’s syndrome, other pervasive developmental diseases, autistic disorder, and autism spectrum disorder are all found to be statistically significantly associated with a higher vaccine-derived aluminum cumulative dose.
No takes yet. Share an insight, caveat, or question.
Jablonowski et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: